Ac. Justus et al., ANTITHROMBIN BINDING BY HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS - EFFECTS OF EXOGENOUS HEPARIN, Thrombosis research, 79(2), 1995, pp. 175-186
Human umbilical vein endothelial cells cultured in growth media that d
id not contain exogenous heparin were found to grow less well while bi
nding significantly more antithrombin (AT) than comparable cells cultu
red in growth media that did contain exogenous heparin (90 mu g/ml). T
he binding of AT to plasma membranes of cultured endothelial cells was
measured immunologically by flow cytometry. This binding was eliminat
ed completely by reacting the cells with heparinase III before incubat
ing them with AT, indicating that the most likely heparinase-sensitive
process responsible for AT binding to plasma membranes was heparan su
lfate proteoglycan. Increased AT binding also was promoted by addition
of heparin-binding molecules (protamine, AT, or ECGF) to growth media
, and the effects of other glycosaminoglycans and dextran on AT bindin
g were found to be dependent on their sulfation. Thus, one response of
endothelial cells to heparin deficiency is up-regulation of the abili
ty to bind AT to plasma membranes.